Skip to main content

Table 3 Precision of the current approach at two levels

From: Nano-level assay of attention-deficit/hyperactivity disorder medicament, atomoxetine by molecular-size-based resonance rayleigh scattering strategy. Employment in content uniformity, dosage form, and plasma analysis

Conc. Level (ng/mL)

Intraday precision

Interday precision

Recovery*± SD

% RSD

Recovery*± SD

% RSD

300

100.63 ± 1.25

1.24

99.23 ± 1.19

1.19

750

98.89 ± 1.32

1.34

100.60 ± 1.65

1.64

950

100.85 ± 1.02

1.01

101.08 ± 1.38

1.36

  1. *mean of three ATX determinations and RSD is the relative standard deviation
Back to article page

BMC Chemistry

ISSN: 2661-801X

Contact us